Inventor · disambiguated record
Longcheng Wang
Also filed as: WANG LONGCHENG
15 granted patents·13 pending applications·138 citations·filing 2003–2021
92Inventor score
Top patents by PatentIndex Score
28 records- 0194US9540385B2Pyrrolopyrimidine compounds as kinase inhibitorsPHARMACYCLICS LLC·Filed 2015·Granted Jan 10, 2017·18 cites·26 claims
- 0294US7704995B2Protein kinase modulators and methods of useEXELIXIS INC·Filed 2003·Granted Apr 27, 2010·64 cites·35 claims
- 0389US9533991B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Jan 3, 2017·3 cites·20 claims
- 0488US8044062B2Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alphaEXELIXIS INC·Filed 2006·Granted Oct 25, 2011·15 cites·37 claims
- 0585US9708326B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2014·Granted Jul 18, 2017·4 cites·18 claims
- 0684US9862722B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Jan 9, 2018·4 cites·15 claims
- 0784US9624224B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2014·Granted Apr 18, 2017·6 cites·20 claims
- 0883US9096604B2Pyrrolopyrimidine compounds as kinase inhibitorsPHARMACYCLICS INC·Filed 2013·Granted Aug 4, 2015·5 cites·24 claims
- 0982US9469642B2Purinone compounds as kinase inhibitorsPHARMACYCLICS LLC·Filed 2013·Granted Oct 18, 2016·4 cites·2 claims
- 1082US8247408B2Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancerBAIK TAE-GON·Filed 2006·Granted Aug 21, 2012·10 cites·35 claims
- 1175US9138436B2Inhibitors of Bruton's tyrosine kinaseCHEN WEI·Filed 2012·Granted Sep 22, 2015·2 cites·6 claims
- 1274US9580416B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Feb 28, 2017·2 cites·18 claims
- 1369US8012956B2Tropane compoundsEXELIXIS INC·Filed 2008·Granted Sep 6, 2011·1 cites·18 claims
- 1468US2010209340A1Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancerBUHR CHRIS A·Filed 2008·Application pending·0 cites
- 1562US2019112312A1Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 1659US2013343988A1Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of P13K-Alpha for the treament of cancerEXELIXIS INC·Filed 2013·Application pending·0 cites
- 1757US2017015671A1Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 1854US2022213092A1Bicyclic pyrazole bruton's tyrosine kinase inhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 1952US7768003B2Formation of p-n homogeneous junctionsUNIV TEXAS·Filed 2007·Granted Aug 3, 2010·0 cites·19 claims
- 2051US2016368924A1Purinone compounds as kinase inhibitorsPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 2151US2016375026A1Pyrrolopyrimidine compounds as kinase inhibitorsPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 2250US2010150827A1Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancerEXELIXIS INC·Filed 2008·Application pending·0 cites
- 2346US2017050970A1Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 2444US2011237608A1Pyridopyrimidinone Inhibitors of PI3KalphaEXELIXIS INC·Filed 2011·Application pending·0 cites
- 2544US2009203577A1Azepinoindole Derivatives As Pharmaceutical AgentsEXELIXIS INC·Filed 2006·Application pending·0 cites
- 2640US8710038B2Pyrazole kinase modulators and methods of useBAIK TAE-GON·Filed 2005·Granted Apr 29, 2014·0 cites·8 claims
- 2738US2018194762A1PYRAZOLO[3,4-b]PYRIDINE AND PYRROLO[2,3-b]PYRIDINE INHIBITORS OF BRUTON'S TYROSINE KINASEPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 2835US2010305093A1Inhibitors of mTOR and Methods of Making and UsingEXELIXIS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Longcheng Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →